LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,322 | -15.6% | 6,731 | +1.5% | 0.00% | 0.0% |
| Q2 2023 | $478,095 | +12.3% | 6,631 | +14.6% | 0.00% | 0.0% |
| Q1 2023 | $425,692 | +10.1% | 5,787 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $386,572 | -22.4% | 5,787 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $498,319 | -3.4% | 5,787 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $516,000 | -23.6% | 5,787 | -3.5% | 0.00% | 0.0% |
| Q1 2022 | $675,000 | -25.8% | 5,999 | +1.9% | 0.00% | -50.0% |
| Q4 2021 | $910,000 | -29.0% | 5,890 | -36.0% | 0.00% | -33.3% |
| Q3 2021 | $1,282,000 | +5.0% | 9,203 | -1.1% | 0.00% | +50.0% |
| Q2 2021 | $1,221,000 | -17.2% | 9,310 | -3.8% | 0.00% | -33.3% |
| Q1 2021 | $1,475,000 | +55.8% | 9,676 | +1.6% | 0.00% | +50.0% |
| Q4 2020 | $947,000 | +25.3% | 9,520 | +20.1% | 0.00% | 0.0% |
| Q3 2020 | $756,000 | +15.4% | 7,928 | +35.3% | 0.00% | 0.0% |
| Q2 2020 | $655,000 | +4.1% | 5,860 | -32.2% | 0.00% | 0.0% |
| Q1 2020 | $629,000 | -72.2% | 8,646 | -60.1% | 0.00% | -60.0% |
| Q4 2019 | $2,261,000 | -53.6% | 21,680 | -55.8% | 0.01% | -54.5% |
| Q3 2019 | $4,877,000 | -80.7% | 48,997 | -77.9% | 0.01% | -79.6% |
| Q2 2019 | $25,277,000 | -3.4% | 221,438 | +6.4% | 0.05% | -8.5% |
| Q1 2019 | $26,168,000 | +2.2% | 208,155 | +10.3% | 0.06% | -6.3% |
| Q4 2018 | $25,611,000 | -37.2% | 188,730 | +27.0% | 0.06% | -25.0% |
| Q3 2018 | $40,789,000 | +33.4% | 148,597 | +0.7% | 0.08% | +29.2% |
| Q2 2018 | $30,584,000 | +25.2% | 147,626 | -0.2% | 0.06% | +25.0% |
| Q1 2018 | $24,435,000 | +1161.5% | 147,940 | +945.7% | 0.05% | +1200.0% |
| Q4 2017 | $1,937,000 | -0.5% | 14,147 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $1,946,000 | -92.3% | 14,296 | -93.2% | 0.00% | -93.0% |
| Q2 2017 | $25,403,000 | +12.4% | 209,256 | -2.0% | 0.06% | +9.6% |
| Q1 2017 | $22,591,000 | +22.4% | 213,441 | +17.5% | 0.05% | +18.2% |
| Q4 2016 | $18,462,000 | +3.1% | 181,690 | +3.6% | 0.04% | +29.4% |
| Q3 2016 | $17,902,000 | -10.8% | 175,411 | +4.3% | 0.03% | -30.6% |
| Q2 2016 | $20,064,000 | +1506.4% | 168,223 | +1342.1% | 0.05% | +1533.3% |
| Q1 2016 | $1,249,000 | +44.9% | 11,665 | +46.7% | 0.00% | +50.0% |
| Q4 2015 | $862,000 | +26.6% | 7,951 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $681,000 | -31.4% | 7,951 | -19.1% | 0.00% | 0.0% |
| Q2 2015 | $992,000 | +4.1% | 9,831 | -20.5% | 0.00% | 0.0% |
| Q1 2015 | $953,000 | +32.4% | 12,364 | -8.6% | 0.00% | 0.0% |
| Q4 2014 | $720,000 | +13.4% | 13,524 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $635,000 | -24.6% | 13,524 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $842,000 | -13.8% | 13,524 | -6.9% | 0.00% | 0.0% |
| Q1 2014 | $977,000 | +27.9% | 14,522 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $764,000 | +21.5% | 14,522 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $629,000 | +15.8% | 14,522 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $543,000 | – | 14,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |